154 related articles for article (PubMed ID: 26302794)
1. Targeting the Eph-ephrin System with Protein-Protein Interaction (PPI) Inhibitors.
Tognolini M; Lodola A
Curr Drug Targets; 2015; 16(10):1048-56. PubMed ID: 26302794
[TBL] [Abstract][Full Text] [Related]
2. Eph Receptors as Drug Targets: Single-Chain Antibodies and Beyond.
Lamminmaki U; Nikolov D; Himanen J
Curr Drug Targets; 2015; 16(10):1021-30. PubMed ID: 26028047
[TBL] [Abstract][Full Text] [Related]
3. Targeting Eph/ephrin system in cancer therapy.
Lodola A; Giorgio C; Incerti M; Zanotti I; Tognolini M
Eur J Med Chem; 2017 Dec; 142():152-162. PubMed ID: 28780190
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Eph receptor-ephrin ligand interaction by tea polyphenols.
Noberini R; Koolpe M; Lamberto I; Pasquale EB
Pharmacol Res; 2012 Oct; 66(4):363-73. PubMed ID: 22750215
[TBL] [Abstract][Full Text] [Related]
5. Editorial: Small Molecules and Peptides Targeting the Eph-Ephrin System.
Tognolini M; Lodola A
Curr Drug Targets; 2015; 16(10):1020. PubMed ID: 26435471
[No Abstract] [Full Text] [Related]
6. Δ(5)-Cholenoyl-amino acids as selective and orally available antagonists of the Eph-ephrin system.
Castelli R; Tognolini M; Vacondio F; Incerti M; Pala D; Callegari D; Bertoni S; Giorgio C; Hassan-Mohamed I; Zanotti I; Bugatti A; Rusnati M; Festuccia C; Rivara S; Barocelli E; Mor M; Lodola A
Eur J Med Chem; 2015 Oct; 103():312-24. PubMed ID: 26363867
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic perspectives of Eph-ephrin system modulation.
Tognolini M; Hassan-Mohamed I; Giorgio C; Zanotti I; Lodola A
Drug Discov Today; 2014 May; 19(5):661-9. PubMed ID: 24291785
[TBL] [Abstract][Full Text] [Related]
8. Targeting Eph receptors with peptides and small molecules: progress and challenges.
Noberini R; Lamberto I; Pasquale EB
Semin Cell Dev Biol; 2012 Feb; 23(1):51-7. PubMed ID: 22044885
[TBL] [Abstract][Full Text] [Related]
9. A disalicylic acid-furanyl derivative inhibits ephrin binding to a subset of Eph receptors.
Noberini R; De SK; Zhang Z; Wu B; Raveendra-Panickar D; Chen V; Vazquez J; Qin H; Song J; Cosford ND; Pellecchia M; Pasquale EB
Chem Biol Drug Des; 2011 Oct; 78(4):667-78. PubMed ID: 21791013
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological evaluation of new bioavailable small molecules targeting Eph/ephrin interaction.
Giorgio C; Incerti M; Corrado M; Rusnati M; Chiodelli P; Russo S; Callegari D; Ferlenghi F; Ballabeni V; Barocelli E; Lodola A; Tognolini M
Biochem Pharmacol; 2018 Jan; 147():21-29. PubMed ID: 29129483
[TBL] [Abstract][Full Text] [Related]
11. On the use of 2,5-dimethyl-pyrrol-1-yl-benzoic acid derivatives as EPH-ephrin antagonists.
Lodola A; Incerti M; Tognolini M
J Virol; 2014 Oct; 88(20):12173. PubMed ID: 25246598
[No Abstract] [Full Text] [Related]
12. Reply to "On the use of 2,5-dimethyl-pyrrol-1-yl-benzoic acid derivatives as EPH-ephrin antagonists".
Desrosiers RC; Hahn AS
J Virol; 2014 Oct; 88(20):12174. PubMed ID: 25246599
[No Abstract] [Full Text] [Related]
13. The role of ephrins and Eph receptors in cancer.
Surawska H; Ma PC; Salgia R
Cytokine Growth Factor Rev; 2004 Dec; 15(6):419-33. PubMed ID: 15561600
[TBL] [Abstract][Full Text] [Related]
14. Interaction between ephrins/Eph receptors and excitatory amino acid receptors: possible relevance in the regulation of synaptic plasticity and in the pathophysiology of neuronal degeneration.
Calò L; Cinque C; Patanè M; Schillaci D; Battaglia G; Melchiorri D; Nicoletti F; Bruno V
J Neurochem; 2006 Jul; 98(1):1-10. PubMed ID: 16805791
[TBL] [Abstract][Full Text] [Related]
15. Combining ligand- and structure-based approaches for the discovery of new inhibitors of the EPHA2-ephrin-A1 interaction.
Pala D; Castelli R; Incerti M; Russo S; Tognolini M; Giorgio C; Hassan-Mohamed I; Zanotti I; Vacondio F; Rivara S; Mor M; Lodola A
J Chem Inf Model; 2014 Oct; 54(10):2621-6. PubMed ID: 25289483
[TBL] [Abstract][Full Text] [Related]
16. Eph-ephrin bidirectional signaling in physiology and disease.
Pasquale EB
Cell; 2008 Apr; 133(1):38-52. PubMed ID: 18394988
[TBL] [Abstract][Full Text] [Related]
17. The role of the Eph-ephrin signalling system in the regulation of developmental patterning.
Coulthard MG; Duffy S; Down M; Evans B; Power M; Smith F; Stylianou C; Kleikamp S; Oates A; Lackmann M; Burns GF; Boyd AW
Int J Dev Biol; 2002; 46(4):375-84. PubMed ID: 12141423
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of small molecule agonists of EphA2 receptor.
Petty A; Idippily N; Bobba V; Geldenhuys WJ; Zhong B; Su B; Wang B
Eur J Med Chem; 2018 Jan; 143():1261-1276. PubMed ID: 29128116
[TBL] [Abstract][Full Text] [Related]
19. Small-molecule stabilization of protein-protein interactions: an underestimated concept in drug discovery?
Thiel P; Kaiser M; Ottmann C
Angew Chem Int Ed Engl; 2012 Feb; 51(9):2012-8. PubMed ID: 22308055
[TBL] [Abstract][Full Text] [Related]
20. Fragment based lead discovery of small molecule inhibitors for the EPHA4 receptor tyrosine kinase.
van Linden OP; Farenc C; Zoutman WH; Hameetman L; Wijtmans M; Leurs R; Tensen CP; Siegal G; de Esch IJ
Eur J Med Chem; 2012 Jan; 47(1):493-500. PubMed ID: 22137457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
